Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 3,327.00
+7.40 (0.22%)
Nov 12, 2026, 3:29 PM IST
Ajanta Pharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 919.5 | 1,033 | 1,751 | 1,295 | 3,298 | 2,064 |
Short-Term Investments | 5,881 | - | - | - | - | - |
Trading Asset Securities | - | 5,599 | 4,387 | 3,301 | 5,103 | 1,219 |
Cash & Short-Term Investments | 6,800 | 6,631 | 6,138 | 4,595 | 8,401 | 3,282 |
Cash Growth | -27.66% | 8.03% | 33.58% | -45.30% | 155.96% | -13.21% |
Accounts Receivable | 18,636 | 18,539 | 11,827 | 12,468 | 10,569 | 10,198 |
Other Receivables | 34.4 | 1,454 | 412 | 696.6 | 459.2 | 460.5 |
Receivables | 18,685 | 20,010 | 12,265 | 13,505 | 11,202 | 10,722 |
Inventory | 9,666 | 9,385 | 9,039 | 8,284 | 8,156 | 7,911 |
Prepaid Expenses | - | 325.5 | 245.8 | 259.2 | 164.4 | 155.8 |
Other Current Assets | 3,081 | 1,002 | 742.9 | 666.4 | 416.2 | 573.6 |
Total Current Assets | 38,233 | 37,354 | 28,430 | 27,309 | 28,340 | 22,645 |
Property, Plant & Equipment | 22,072 | 20,834 | 18,918 | 17,210 | 16,982 | 16,474 |
Long-Term Investments | 320.7 | 285 | 252.4 | 227.4 | 290 | 294.2 |
Other Intangible Assets | 458.4 | 415.8 | 465.2 | 146.6 | 77.5 | 90.2 |
Long-Term Deferred Tax Assets | 1,854 | 1,886 | 1,864 | 1,345 | 967.7 | 555.5 |
Other Long-Term Assets | 1,316 | 773.2 | 219.6 | 146.4 | 133.4 | 497.1 |
Total Assets | 64,253 | 61,548 | 50,150 | 46,384 | 46,790 | 40,556 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 5,712 | 5,443 | 4,542 | 4,632 | 4,228 | 3,272 |
Accrued Expenses | 323.8 | 3,749 | 3,354 | 671.3 | 356.8 | 375.9 |
Short-Term Debt | - | 57.4 | 35 | 30.5 | 38.4 | 94.9 |
Current Portion of Leases | 1,169 | 2,208 | 127 | 102.7 | 94.3 | 64.6 |
Current Income Taxes Payable | 751.8 | 54.9 | 405.3 | 447.7 | 330.7 | 79.4 |
Current Unearned Revenue | - | - | - | 3.3 | 3.3 | 3.3 |
Other Current Liabilities | 5,471 | 2,645 | 1,498 | 3,070 | 6,342 | 2,584 |
Total Current Liabilities | 13,428 | 14,158 | 9,961 | 8,958 | 11,393 | 6,474 |
Long-Term Leases | 372.6 | 394.2 | 347.2 | 235.2 | 262 | 185.7 |
Long-Term Unearned Revenue | 15 | 16.7 | 20 | 23.4 | 26.7 | 30 |
Pension & Post-Retirement Benefits | - | 83.7 | 468.6 | 135 | 23.2 | - |
Long-Term Deferred Tax Liabilities | 1,077 | 1,179 | 1,105 | 1,085 | 977.2 | 1,019 |
Other Long-Term Liabilities | 777.1 | 446 | 344.6 | 274.1 | 228.4 | 204.1 |
Total Liabilities | 15,670 | 16,278 | 12,247 | 10,710 | 12,910 | 7,912 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 250.7 | 250.7 | 250.7 | 251.8 | 251.8 | 170.8 |
Additional Paid-In Capital | - | 71.6 | 36.6 | 1.8 | - | - |
Retained Earnings | - | 44,496 | 37,434 | 35,254 | 33,523 | 32,495 |
Comprehensive Income & Other | 48,332 | 452.4 | 181.2 | 166.2 | 105 | -22.1 |
Shareholders' Equity | 48,583 | 45,271 | 37,903 | 35,674 | 33,880 | 32,643 |
Total Liabilities & Equity | 64,253 | 61,548 | 50,150 | 46,384 | 46,790 | 40,556 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 1,542 | 2,659 | 509.2 | 368.4 | 394.7 | 345.2 |
Net Cash (Debt) | 5,259 | 3,972 | 5,629 | 4,227 | 8,006 | 2,937 |
Net Cash Growth | -24.25% | -29.44% | 33.17% | -47.20% | 172.60% | -13.73% |
Net Cash Per Share | 42.07 | 31.79 | 44.97 | 33.55 | 62.49 | 22.65 |
Filing Date Shares Outstanding | 124.92 | 124.94 | 125.68 | 126.68 | 125.91 | 128.12 |
Total Common Shares Outstanding | 124.92 | 124.94 | 125.68 | 126.68 | 125.91 | 128.12 |
Working Capital | 24,805 | 23,197 | 18,469 | 18,352 | 16,947 | 16,171 |
Book Value Per Share | 388.90 | 362.35 | 301.59 | 281.60 | 269.07 | 254.78 |
Tangible Book Value | 48,124 | 44,855 | 37,438 | 35,527 | 33,802 | 32,553 |
Tangible Book Value Per Share | 385.23 | 359.03 | 297.88 | 280.44 | 268.45 | 254.08 |
Land | - | 1,510 | 1,467 | 1,488 | 1,577 | 1,575 |
Buildings | - | 8,697 | 8,113 | 6,174 | 6,057 | 5,870 |
Machinery | - | 18,024 | 16,364 | 14,692 | 13,879 | 13,276 |
Construction In Progress | - | 2,581 | 1,763 | 2,565 | 2,095 | 1,529 |
Leasehold Improvements | - | - | - | - | - | 10.9 |